Literature DB >> 29098683

Effect of sufentanil on bispectral index in the elderly.

T de Valence1, N Elia1,2, C Czarnetzki1, L Dumont1,3, M R Tramèr1,3, C Lysakowski1,3.   

Abstract

We examined the impact of adding sufentanil during anaesthesia induction with propofol on bispectral index values in elderly patients (≥ 65 years). Patients were randomly assigned to receive a target-controlled sufentanil infusion (effect-site concentration of 0.3 ng.ml-1 ) or matching placebo, followed by a target-controlled propofol induction (initial effect-site concentration of 0.5 μg.ml-1 ; step-wise increase of 0.5 μg.ml-1 ) until loss of consciousness defined as an Observer's Assessment of Alertness/Sedation score < 2. Seventy-one patients (sufentanil 35, placebo 36) completed the study. Mean (SD) age was 72.3 (5.8) years; 41% were women. At loss of consciousness, mean (SD) bispectral index value was 75.0 (8.6) with sufentanil and 70.0 (8.0) with placebo; mean difference -5.0 (95% confidence interval -8.9 to -1.1), p = 0.013. Post-hoc analyses suggest that the difference was significant in men only (mean difference -7.3 (-11.8 to -2.6), p = 0.003). Sufentanil co-induction with propofol results in higher bispectral index values at loss of consciousness in elderly patients.
© 2017 The Association of Anaesthetists of Great Britain and Ireland.

Entities:  

Keywords:  zzm321990EEGzzm321990; elderly; monitoring; opioids; sufentanil

Mesh:

Substances:

Year:  2017        PMID: 29098683     DOI: 10.1111/anae.14102

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  2 in total

1.  Application of propofol combined with sevoflurane anesthesia in staged hepatectomy liver detachment and portal vein ligation.

Authors:  Fei Xu; Hongbo Jiang; Meishan Jin; Qihua Peng
Journal:  Exp Ther Med       Date:  2021-06-30       Impact factor: 2.447

2.  The effects of different doses of dexmedetomidine on the requirements for propofol for loss of consciousness in patients monitored via the bispectral index: a double-blind, placebo-controlled trial.

Authors:  Yang Gu; Fan Yang; Yonghai Zhang; Junwei Zheng; Jie Wang; Bin Li; Tao Ma; Xiang Cui; Kaimei Lu; Hanxiang Ma
Journal:  BMC Anesthesiol       Date:  2020-04-25       Impact factor: 2.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.